Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Yifan Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,232	18,014	15,019	21,745	23,372	17,082
Market Cap Growth	-7.91%	19.94%	-30.93%	-6.96%	36.83%	32.27%
Enterprise Value	15,563	19,400	16,499	22,717	23,710	17,640
Last Close Price	11.70	14.64	12.13	17.45	18.70	15.97
PE Ratio	-	-	78.54	78.11	24.14	18.91
Forward PE	28.19	7.82	7.82	7.82	7.82	7.82
PS Ratio	2.86	4.43	3.92	4.93	4.33	3.29
PB Ratio	1.67	2.18	1.64	2.48	2.68	2.18
P/TBV Ratio	3.87	4.67	2.82	4.23	4.70	4.22
P/FCF Ratio	-	-	-	59.50	240.02
P/OCF Ratio	34.61	51.68	31.82	72.19	21.09	18.23
EV/Sales Ratio	3.12	4.77	4.30	5.15	4.39	3.40
EV/EBITDA Ratio	34.90	72.38	43.52	50.06	19.91	14.47
EV/EBIT Ratio	102.85	926.80	96.29	86.48	23.38	16.56
EV/FCF Ratio	-209.16	-	-	-	60.36	247.87
Debt / Equity Ratio	0.30	0.24	0.24	0.26	0.19	0.24
Debt / EBITDA Ratio	5.62	6.97	5.44	4.84	1.39	1.57
Debt / FCF Ratio	-	-	-	-	4.23	26.87
Asset Turnover	0.40	0.34	0.31	0.37	0.48	0.50
Inventory Turnover	2.65	2.43	2.65	4.16	4.91	5.22
Quick Ratio	0.89	0.94	1.19	1.13	1.22	0.93
Current Ratio	1.32	1.49	1.68	1.56	1.65	1.22
Return on Equity (ROE)	-7.68%	-10.18%	1.42%	2.77%	11.25%	11.87%
Return on Assets (ROA)	0.77%	0.11%	0.87%	1.38%	5.58%	6.39%
Return on Capital (ROIC)	0.85%	0.12%	0.96%	1.53%	6.30%	7.37%
Return on Capital Employed (ROCE)	1.60%	0.20%	1.70%	2.70%	10.70%	13.00%
Earnings Yield	-2.33%	-3.06%	1.27%	1.28%	4.14%	5.29%
FCF Yield	-0.52%	-0.86%	-0.47%	-1.24%	1.68%	0.42%
Dividend Yield	1.68%	-	-	-	0.27%	0.63%
Payout Ratio	0.00%	-	45.18%	49.71%	20.86%	21.29%
Buyback Yield / Dilution	1.37%	3.94%	-5.32%	1.26%	-0.40%	-0.99%
Total Shareholder Return	3.05%	3.94%	-5.32%	1.26%	-0.14%	-0.37%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.